DS

David Sinclair

Professor at Harvard Medical School

Greater Boston

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Professor

    1999

2008

  • Co-Editor in Chief

    2008

    A scientific journal that publishes papers in all disciplines relevant to aging.

  • Board Member, Investor, Advisor

    2017

    Life Biosciences is a leader in developing pharmaceuticals based on the science of aging. It is the parent company of Senolytic Therapeutics, Jumpstart Fertility, Continuum Biosciences, Selphagy, Animal Biosciences, Lua Communications.

Metrobiotech International

2013

  • Co-founder, Board Member, Scientific Advisor, Investor

    2013

  • Co-Founder

    2012

Fully Aligned Co, LLC

2022

  • Co-Founder

    2022

    In 2022, Professor David A. Sinclair, A.O., Ph.D. and Serena Poon CN, CHC, CHN co-founded Fully Aligned Co, LLC, a conscious company backed by research, with the intentions of Bridging the Science and Soul for Well-Being™. As world-renowned experts in health, wellness and longevity, David and Serena produce content, products and services designed to democratize access to knowledge and tools that enhance well-being and maximize healthy lifespan

  • Co-Founder

    2018

    Maker of Leap Years (R) supplements to increase vitality and the healthy years of life for companion animals.

Immetas Therapeutics

2020

  • Co-founder, Board member

    2020

  • Co-Founder, Board Member, Advisor, Investor

    2016

  • Scientific Advisor, Investor

    2011

    Personalized Health IT